Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.64
7.61
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Shandong Weigao Group Medical Polymer Co Ltd
Shandong Weigao Group Medical Polymer Co Ltd
Total Liabilities & Equity
Shandong Weigao Group Medical Polymer Co Ltd
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Total Liabilities & Equity
¥34.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
|
Total Liabilities & Equity
¥3.1B
|
CAGR 3-Years
23%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Total Liabilities & Equity
¥11B
|
CAGR 3-Years
9%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
Winner Medical Co Ltd
SZSE:300888
|
Total Liabilities & Equity
¥17.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Total Liabilities & Equity
¥8.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Intco Medical Technology Co Ltd
SZSE:300677
|
Total Liabilities & Equity
¥31.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
63%
|
CAGR 10-Years
N/A
|
|
Shandong Weigao Group Medical Polymer Co Ltd
Glance View
Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of medical devices. The company is headquartered in Weihai, Shandong. The company went IPO on 2004-02-27. The firm sells products under brand names of Jierui and Wego Ortho. The firm operates through three business segments. The Single Use Medical Device Products segment is engaged in the production and sale of single-use consumables, such as infusion sets, syringes, blood transfusion sets and blood bags. The Orthopaedic Products segment is engaged in the production and sale of orthopaedic products. The Blood Purification Products segment is engaged in the production and sale of blood purification products and related medical equipment. The firm is also engaged in the manufacture of industrial automatic equipment and parts, as well as the provision of logistics and storage services through its subsidiaries.
See Also
What is Shandong Weigao Group Medical Polymer Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
34.5B
CNY
Based on the financial report for Jun 30, 2024, Shandong Weigao Group Medical Polymer Co Ltd's Total Liabilities & Equity amounts to 34.5B CNY.
What is Shandong Weigao Group Medical Polymer Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
7%
Over the last year, the Total Liabilities & Equity growth was 2%. The average annual Total Liabilities & Equity growth rates for Shandong Weigao Group Medical Polymer Co Ltd have been 5% over the past three years , 7% over the past five years .
You don't have any saved screeners yet
